• News
  • BioTech

La Jolla Pharmaceutical to be listed on Nasdaq

La Jolla Pharmaceutical Co. (Nasdaq: LJPC), a developer of therapeutics targeting significant unmet life-threatening diseases, Wednesday announced that it has received approval to list its common stock on the Nasdaq Capital Market starting Wednesday.

To continue reading, subscribe now
log in to your account
User Response
0 UserComments
Subscribe Today!